Search

Your search keyword '"Clinical Trials, Phase II as Topic standards"' showing total 7 results
Start Over Descriptor "Clinical Trials, Phase II as Topic standards" Publication Type Magazines
7 results on '"Clinical Trials, Phase II as Topic standards"'

1. Italy launches clinical trial for HIV vaccine.

Subjects
Animals, Clinical Trials, Phase I as Topic standards, HIV Infections immunology, HIV Infections prevention & control, Humans, Italy, tat Gene Products, Human Immunodeficiency Virus immunology, AIDS Vaccines economics, AIDS Vaccines immunology, Clinical Trials, Phase II as Topic standards
Published
2008
Full Text
View/download PDF

3. Examining heterogeneity in phase II trial designs may improve success in phase III.

Author

Tuma RS

Subjects
Benzenesulfonates administration & dosage, Confounding Factors, Epidemiologic, Humans, Niacinamide analogs & derivatives, Phenylurea Compounds, Pyridines administration & dosage, Randomized Controlled Trials as Topic standards, Sorafenib, Treatment Outcome, Antineoplastic Agents therapeutic use, Clinical Trials, Phase II as Topic standards, Clinical Trials, Phase III as Topic standards, Neoplasms drug therapy, Research Design
Published
2008
Full Text
View/download PDF

4. Criticism of tumor response criteria raises trial design questions.

Author

Twombly R

Subjects
Antineoplastic Agents therapeutic use, Biomarkers, Tumor metabolism, Clinical Trials, Phase II as Topic standards, Disease Progression, Disease-Free Survival, Humans, Neoplasms metabolism, Neoplasms pathology, Randomized Controlled Trials as Topic standards, Reproducibility of Results, Treatment Outcome, Antineoplastic Agents pharmacology, Drug Evaluation standards, Neoplasms drug therapy, Research Design standards
Published
2006
Full Text
View/download PDF

5. Standardization, more funds on horizon for clinical trials.

Author

McNeil C

Subjects
Clinical Trials, Phase I as Topic economics, Clinical Trials, Phase I as Topic standards, Clinical Trials, Phase II as Topic economics, Clinical Trials, Phase II as Topic standards, Clinical Trials, Phase III as Topic economics, Clinical Trials, Phase III as Topic standards, Humans, National Institutes of Health (U.S.), United States, Clinical Trials as Topic economics, Clinical Trials as Topic standards, Research Support as Topic
Published
2005
Full Text
View/download PDF

6. Despite concerns, FDA panel backs EGFR inhibitor.

Author

Twombly R

Subjects
Antineoplastic Agents adverse effects, Clinical Trials as Topic, Clinical Trials, Phase II as Topic standards, Gefitinib, Humans, Quinazolines adverse effects, United States, Antineoplastic Agents therapeutic use, ErbB Receptors antagonists & inhibitors, Lung Neoplasms drug therapy, Quinazolines therapeutic use, United States Food and Drug Administration
Published
2002
Full Text
View/download PDF

7. Antisense against protein kinase C-alpha mRNA makes sense for cancer therapy?

Author

Stewart A

Subjects
Animals, Antineoplastic Agents pharmacology, Clinical Trials, Phase I as Topic standards, Clinical Trials, Phase II as Topic standards, Enzyme Inhibitors pharmacology, Humans, Oligonucleotides, Antisense pharmacology, Protein Kinase C-alpha, Thionucleotides pharmacology, Antineoplastic Agents therapeutic use, Enzyme Inhibitors therapeutic use, Isoenzymes antagonists & inhibitors, Neoplasms drug therapy, Oligodeoxyribonucleotides, Antisense, Oligonucleotides, Antisense therapeutic use, Protein Kinase C antagonists & inhibitors, RNA, Messenger metabolism, Thionucleotides therapeutic use
Published
1997
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results